HER2 + BREAST CANCER
Clinical trials for HER2 + BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo challenges standard treatment in breast cancer trial
Disease control Not yet recruitingThis study is testing whether two new experimental drugs (HLX87 and HLX22) work better than the current standard treatment when given before surgery for HER2-positive breast cancer. Researchers will enroll 817 adults with early-stage or locally advanced HER2-positive breast cance…
Matched conditions: HER2 + BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Study aims to spare breast cancer patients from chemotherapy
Disease control Not yet recruitingThis study is testing if some patients with a common type of early breast cancer can avoid chemotherapy before surgery. Instead, they would receive a targeted pill (abemaciclib) plus hormone therapy. The goal is to see if this gentler approach works as well for shrinking tumors, …
Matched conditions: HER2 + BREAST CANCER
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC